ITW Reagents is fully integrated by AppliChem GmbH and PanReac Química SLU companies, under unique commercial brand PanReac AppliChem since 2014.
With 75 years’ of experience, ITW Reagents is a Chemical producer of high quality chemicals for pharmaceutical manufacturing processes.
One of these processes is the pH adjustment in pharmaceutical production. In this process it is important to use reagents of the appropriate quality grade. Laboratory products are not suitable for this particular application as some important certificates requested by authorities will be missing.
PanReac AppliChem offers the right product for your needs with the necessary documentation.
Main advantages:
Our product range cover different concentrations of hydrochloric acid, acetic acid, ortho-phosphoric acid, sodium hydroxide and ammonia, among others.
ITW Reagents has two production plants (in Barcelona, Spain and Darmstadt, Germany) and three logistics centers of 20,000 m2 (in Barcelona, Spain; Darmstadt, Germany and Milan, Italy) to address our client needs.
For further information contact us at customerservice.es@itwreagents.com
Company name: ITW REAGENTS
Website: www.itwreagents.com
E-mail: customerservice.es@itwreagents.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.